CIK 0001821825
- Large accelerated filer
Organon & Co.
Sign in to watch- Ticker
- OGN
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 464838035
- Phone
- +1 551-430-6000
- Business address
- 30 HUDSON STREET, FL 33, JERSEY CITY, NJ, 07302
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 84 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-03-31 | Falcione Aaron Chief Human Resources Officer | Option exercise · Restricted Stock Units | −3,578 | 3,579 | ||
| 2024-03-31 | Falcione Aaron Chief Human Resources Officer | Option exercise · Restricted Stock Units | −6,731 | 13,464 | ||
| 2024-03-31 | Weaver Kirke Gen. Counsel & Corp. Secy. | Option exercise | +4,294 | 22,825 | ||
| 2024-03-31 | Weaver Kirke Gen. Counsel & Corp. Secy. | Shares withheld for taxes | −1,224 | $18.80 | $23K | 21,601 |
| 2024-03-31 | Weaver Kirke Gen. Counsel & Corp. Secy. | Option exercise | +6,200 | 27,801 | ||
| 2024-03-31 | Weaver Kirke Gen. Counsel & Corp. Secy. | Shares withheld for taxes | −1,767 | $18.80 | $33K | 26,034 |
| 2024-03-31 | Weaver Kirke Gen. Counsel & Corp. Secy. | Option exercise | +3,125 | 29,159 | ||
| 2024-03-31 | Weaver Kirke Gen. Counsel & Corp. Secy. | Shares withheld for taxes | −891 | $18.80 | $17K | 28,268 |
| 2024-03-31 | Weaver Kirke Gen. Counsel & Corp. Secy. | Option exercise · Restricted Stock Units | −4,294 | 4,294 | ||
| 2024-03-31 | Weaver Kirke Gen. Counsel & Corp. Secy. | Option exercise · Restricted Stock Units | −3,125 | 3,125 | ||
| 2024-03-31 | Weaver Kirke Gen. Counsel & Corp. Secy. | Option exercise · Restricted Stock Units | −6,200 | 12,400 | ||
| 2024-03-31 | DiMarco Kathryn Corporate Controller | Option exercise | +4,294 | 16,031 | ||
| 2024-03-31 | DiMarco Kathryn Corporate Controller | Shares withheld for taxes | −1,471 | $18.80 | $28K | 14,560 |
| 2024-03-31 | DiMarco Kathryn Corporate Controller | Option exercise | +8,503 | 23,063 | ||
| 2024-03-31 | DiMarco Kathryn Corporate Controller | Shares withheld for taxes | −2,913 | $18.80 | $55K | 20,150 |
| 2024-03-31 | DiMarco Kathryn Corporate Controller | Option exercise · Restricted Stock Units | −4,294 | 4,294 | ||
| 2024-03-31 | DiMarco Kathryn Corporate Controller | Option exercise · Restricted Stock Units | −8,503 | 17,007 | ||
| 2024-03-29 | Arjona Ferreira Juan Camilo Head of R&D & CMO | Grant or award · Restricted Stock Units | +26,595 | 26,595 | ||
| 2024-03-29 | Arjona Ferreira Juan Camilo Head of R&D & CMO | Grant or award · Stock Option (right to buy) | +108,932 | 108,932 | ||
| 2024-03-29 | Ali Kevin Chief Executive Officer | Grant or award · Restricted Stock Units | +146,276 | 146,276 |
Page 22 of 33 · 650 trades